Here, by targeting ATP production through inhibition of ALDH7A1 and mitochondrial complex I, remarkable regression of tumor size and number in xenograft model as well as KPC mouse model based on Kras mutation has been shown. The gene discussed is KRAS; the disease is neoplasm.